Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein as Treatment for Gout Flare
Key Points
To explore the effectiveness of etanercept as a treatment for gout flares in patients resistant to conventional therapies.
Analyzed the potential off-label use of etanercept.
Considered patients experiencing severe side effects from standard treatments.
Evaluated the response in patients with contraindications to other therapies.
Etanercept may provide symptom relief for gout flares.
Patients showed variation in response to treatment.
Some reported improved outcomes compared to traditional therapy.
Abstract
Etanercept might be contemplated for "off-label" use in gout patients who do not respond to standard therapy or glucocorticoid therapy, encounter severe side-effects and contraindications.
Like
Bookmark
Share
Like
Bookmark
Share
Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein as Treatment for Gout Flare | Synapse